We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

21 hedge funds and large institutions have $1.82M invested in Sonoma Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

31% more funds holding

Funds holding: 16 → 21 (+5)

28% more capital invested

Capital invested by funds: $1.42M → $1.82M (+$395K)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BA
Bard Associates
Illinois
+$688K
2
BRWA
B. Riley Wealth Advisors
Florida
+$11.7K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$6.39K
4
BFA
BlackRock Fund Advisors
California
+$4.26K
5
UBS Group
UBS Group
Switzerland
+$2.13K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$78.8K
2
Nomura Holdings
Nomura Holdings
Japan
-$31K
3
Citadel Advisors
Citadel Advisors
Florida
-$26.6K
4
Morgan Stanley
Morgan Stanley
New York
-$12.8K
5
Northern Trust
Northern Trust
Illinois
-$1.07K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$668K +$688K +646 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$541K +$6.39K +6 +1%
BIT
3
BlackRock Institutional Trust
California
$147K – – –
BRWA
4
B. Riley Wealth Advisors
Florida
$137K +$11.7K +11 +9%
Goldman Sachs
5
Goldman Sachs
New York
$79K -$78.8K -74 -49%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$77K – – –
GW
7
GW & Wade
Massachusetts
$52K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$32K -$26.6K -25 -45%
NL
9
NWAM LLC
Washington
$28K – – –
Northern Trust
10
Northern Trust
Illinois
$22K -$1.07K -1 -5%
Bank of America
11
Bank of America
North Carolina
$8K +$1.07K +1 +14%
Wells Fargo
12
Wells Fargo
California
$7K – – –
BFA
13
BlackRock Fund Advisors
California
$4K +$4.26K +4 New
Morgan Stanley
14
Morgan Stanley
New York
$3K -$12.8K -12 -80%
Bank of Montreal
15
Bank of Montreal
Ontario, Canada
$3K – – –
JFGIW
16
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$2K – – –
UBS Group
17
UBS Group
Switzerland
$2K +$2.13K +2 New
LTFS
18
Ladenburg Thalmann Financial Services
Florida
$1K – – –
MFS
19
MSI Financial Services
Massachusetts
$1K – – –
Creative Planning
20
Creative Planning
Kansas
$1K +$1.07K +1 New
WAM
21
Wealthspire Advisors (Maryland)
Maryland
$1K +$1.07K +1 New
Nomura Holdings
22
Nomura Holdings
Japan
– -$31K -26 Closed
Citigroup
23
Citigroup
New York
– +$1.07K +1 New

SNOA Hedge Fund Activity: Q4 2015 in Review

21 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2015, worth a combined $1.82M — up 28% from $1.42M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new SNOA positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Bard Associates, opening a new position worth an estimated $688K. The largest seller was Goldman Sachs, cutting an estimated $78.8K.

  • 21 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2015, up from 16 in Q3 2015.
  • Funds reported $1.82M of Sonoma Pharmaceuticals stock for Q4 2015, up 28% quarter-over-quarter.
  • 6 funds opened new Sonoma Pharmaceuticals positions in Q4 2015 and 1 closed out, a net change of +5 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q4 2015 was Bard Associates, an estimated $688K added.
  • The largest Sonoma Pharmaceuticals seller in Q4 2015 was Goldman Sachs, an estimated $78.8K sold.

Based on aggregated 13F filings for Q4 2015.